Literature DB >> 11850761

Decreased plasma orexin-A levels in obese individuals.

J A Adam1, P P C A Menheere, F M H van Dielen, P B Soeters, W A Buurman, J W M Greve.   

Abstract

Orexin-A and -B stimulate appetite and food intake in rats. Orexins and orexin receptors are present in the hypothalamus as well as the enteric nervous system, the pancreas and the gut. The presence of orexins in peripheral blood, however, has not yet been reported. To determine whether orexin-A is present in human plasma and is related to body weight, we measured plasma orexin-A and leptin levels in a population with a body mass index (BMI) range from 19.8 to 59 kg/m(2). Plasma orexin-A levels correlated negatively and plasma leptin levels correlated positively with BMI. In obese and morbidly obese individuals, orexin-A levels were significantly lower and leptin levels were significantly higher when compared to normal. Our results support previous data suggesting that orexin-A acts also in a peripheral manner. The fact that lower levels of plasma orexin-A are present in obese individuals suggests that it is involved in the regulation of human energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850761     DOI: 10.1038/sj.ijo.0801868

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  26 in total

Review 1.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

2.  Orexin A/Hypocretin Modulates Leptin Receptor-Mediated Signaling by Allosteric Modulations Mediated by the Ghrelin GHS-R1A Receptor in Hypothalamic Neurons.

Authors:  Mireia Medrano; David Aguinaga; Irene Reyes-Resina; Enric I Canela; Josefa Mallol; Gemma Navarro; Rafael Franco
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 3.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Inverse Association of Peripheral Orexin-A with Insulin Resistance in Type 2 Diabetes Mellitus: A Randomized Clinical Trial.

Authors:  Mitra Zarifkar; Sina Noshad; Mona Shahriari; Mohsen Afarideh; Elias Khajeh; Zahra Karimi; Alireza Ghajar; Alireza Esteghamati
Journal:  Rev Diabet Stud       Date:  2017-10-10

Review 5.  A serendipitous voyage in the field of nutrition and metabolism in health and disease: a translational adventure.

Authors:  Peter B Soeters
Journal:  Eur J Clin Nutr       Date:  2020-02-14       Impact factor: 4.016

6.  Associations of plasma hypocretin-1 with metabolic and reproductive health: Two systematic reviews of clinical studies.

Authors:  Galit L Dunietz; Giancarlo Vanini; Carol Shannon; Louise M O'Brien; Ronald D Chervin
Journal:  Sleep Med Rev       Date:  2020-03-17       Impact factor: 11.609

7.  Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes.

Authors:  M Skrzypski; T T Le; P Kaczmarek; E Pruszynska-Oszmalek; P Pietrzak; D Szczepankiewicz; P A Kolodziejski; M Sassek; A Arafat; B Wiedenmann; K W Nowak; M Z Strowski
Journal:  Diabetologia       Date:  2011-04-21       Impact factor: 10.122

Review 8.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

9.  Plasma orexin-A level associated with physical activity in obese people.

Authors:  Yuan-Yuan Hao; Hong-Wang Yuan; Peng-Hua Fang; Yu Zhang; Yue-Xia Liao; Chen Shen; Dan Wang; Ting-Ting Zhang; Ping Bo
Journal:  Eat Weight Disord       Date:  2016-04-01       Impact factor: 4.652

10.  Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue.

Authors:  M F Pino; A Divoux; A V Simmonds; S R Smith; L M Sparks
Journal:  Int J Obes (Lond)       Date:  2017-07-04       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.